Trial Profile
Zoledronic acid in the management of malignant pleural mesothelioma - a feasibility study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Feb 2023
Price :
$35
*
At a glance
- Drugs Zoledronic acid (Primary)
- Indications Malignant-mesothelioma
- Focus Therapeutic Use
- Acronyms ZOL-A trial
- 04 Jun 2018 Status changed from active, no longer recruiting to completed.
- 02 Aug 2016 New trial record